US4085204A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for obtaining insulin like active substances
Assignee: ICN Switzerland AG
•
Filing: 1976-12-09
•
Granted: 1978-04-18
•
Expires: 1996-12-09
Abstract
Abstract The invention concerns a novel process for obtaining insulin-like active substances from blood or a blood component of a warm-blooded animal, which comprises the steps of pre-treating the blood or blood component by adjusting the pH thereof to a value of from 2 to 4 or of from 8 to 10, incubating the pre-treated blood at a temperature of from about 15° to about 40° C for a period of at least four hours, cooling the incubated blood to a temperature of less than 10° C, and recovering from the treated blood after neutralization organic peptide substances having a molecular weight of from about 1000 to about 5000, and an insulin-like activity of from about 14 to about 40 μU/mg solid.
Inventors
- 👤 Adolf Wacker
- 👤 Dorthe Wacker
- 👤 Klaus Pohler
- 👤 Hellmut Mittenzwei
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 12:53
CPC Classifications
C; C07; C07K; C07K4/00; C07K4/12; A; A61; A61P; A61P3/00; A61P3/08; A61P3/10; A61P5/00; C07K14/00; C07K14/435; C07K14/575; C07K14/62; C07K14/625; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
155 words
A process for obtaining insulin-like active substances from blood or a blood component of a warm-blooded animal, which comprises the steps of pretreating the blood or blood component by diluting the blood or blood component with from about half to about four volumes of a hydrophilic diluent, adjusting the pH of the resulting solution to a value of from 2 to 4 or of from 8 to 10, incubating the pre-treated blood at a temperature of from about 15 to about 40° C for a period of at least four hours, cooling the incubated blood to a temperature of less than 10° C, dialysing the treated blood after neutralization against a membrane adapted to pass molecules having a molecular weight of less than 6000, and recovering from dialysate organic peptide substances having a molecular weight of from about 1000 to about 5000, and an insulin-like activity of from about 14 to about 40 μU/mg solid.
Claim 2
Dependent Claim
155 words
A process for obtaining insulin-like active substances from blood or a blood component of a warm-blooded animal, which comprises the steps of pretreating the blood or blood component by diluting the blood or blood component with from about half to about four volumes of a hydrophilic diluent, adjusting the pH of the resulting solution to a value of from 2 to 4 or of from 8 to 10, incubating the pre-treated blood at a temperature of from about 15 to about 40° C for a period of at least four hours, cooling the incubated blood to a temperature of less than 10° C, dialysing the treated blood after neutralization against a membrane adapted to pass molecules having a molecular weight of less than 6000, and recovering from dialysate organic peptide substances having a molecular weight of from about 1000 to about 5000, and an insulin-like activity of from about 14 to about 40 μU/mg solid.
Claim 3
Dependent Claim
26 words
A process according to claim 1, in which the blood or blood component employed is one or more of whole blood, plasma, serum and erythrocyte suspension.
Claim 4
Dependent Claim
38 words
A process according to claim 1, in which the blood component employed is the residue remaining after inorganic or organic substances of molecular weight less than about 5000 have been substantially removed from the blood or blood component.
Claim 5
Dependent Claim
39 words
A process according to claim 1, in which the blood component employed is the residue remaining after inorganic or organic substances of a molecular weight less than about 1000 have been substantially removed from the blood or blood component.
Claim 6
Dependent Claim
54 words
A process according to claim 1, in which the recovered insulin-like active substances are subjected to an enrichment process in which inorganic salts and lower molecular weight substances are removed from the recovered substance to obtain an insulin-like active product having an insulin-like activity of from about 35 μU to about 200 μU/mg solid.
Claim 7
Dependent Claim
23 words
A process according to claim 1, in which the recovered insulin-like active substance is concentrated down or diluted to obtain an isotonic solution.
Claim 8
Dependent Claim
45 words
A process according to claim 6, in which the recovered insulin-like active substance is adjusted to obtain an isotonic solution having a solids content of from about 2.5 to about 20 mg/ml, and if necessary to obtain the isotonic solution, adding glucose or sodium chloride.
Claim 9
Dependent Claim
37 words
A process according to claim 6, in which the recovered insulin-like active substance is adjusted to possess an insulin-like activity of about 500 μU/ml and if necessary to obtain an isotonic solution adding glucose or sodium chloride.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-04-17 | 1981-10-17 | 1982-04-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-04-17 | 1985-10-17 | 1986-04-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-04-17 | 1989-10-17 | 1990-04-18 | $7700.00 | Window Closed / Lapsed |